Sheila K Pierson Selected Research

Inflammation (Inflammations)

1/2024	Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.
10/2022	Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine.
1/2021	Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
1/2019	Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.
1/2019	Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheila K Pierson Research Topics

Disease

12	Castleman Disease (Castleman's Disease) 01/2024 - 01/2018
10	Thrombocytopenia (Thrombopenia) 01/2024 - 01/2018
9	Edema (Dropsy) 01/2024 - 01/2018
8	Fever (Fevers) 01/2024 - 01/2019
5	Fibrosis (Cirrhosis) 01/2024 - 01/2018
5	Inflammation (Inflammations) 01/2024 - 01/2019
3	Renal Insufficiency (Renal Failure) 01/2024 - 10/2021
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2019
2	Thrombocytosis (Thrombocythemia) 01/2024 - 04/2022
2	Lymphadenopathy 01/2024 - 04/2022
2	Cytokine Release Syndrome 01/2024 - 01/2018
2	Cytopenia 04/2022 - 01/2019
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 04/2022 - 01/2022
2	Autoimmune Lymphoproliferative Syndrome 01/2022 - 01/2020
2	Weight Loss (Weight Reduction) 10/2015 - 08/2015
1	Hyperplasia 04/2022
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 04/2022
1	Neoplasms (Cancer) 10/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Multi-centric Castleman's Disease 10/2021
1	Disease Progression 01/2018
1	Type 2 Diabetes Mellitus (MODY) 10/2015
1	Morbid Obesity 08/2015
1	Urinary Incontinence 08/2015

Drug/Important Bio-Agent (IBA)

8	Reticulin (Reticular Fiber)IBA 01/2024 - 01/2018
5	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2018
5	CytokinesIBA 10/2022 - 01/2019
3	C-Reactive ProteinIBA 01/2024 - 01/2019
2	siltuximabIBA 10/2022 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	COVID-19 VaccinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2021
1	Monoclonal AntibodiesIBA 01/2019
1	ChemokinesIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Insulin (Novolin)FDA Link 10/2015

Therapy/Procedure

2	Bariatric Surgery 10/2015 - 08/2015
1	Drug Therapy (Chemotherapy) 11/2023
1	Therapeutics 01/2019
1	Precision Medicine 01/2019
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2015